Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.19x
$28.04Latest market snapshot
Implied fair value · at SSNC's multiple
$61.09117.9% above market
2.30 ACAD EPS (TTM)×26.56x SSNC P/E=$61.09
Market $28.04Implied $61.09
SSNC · current priceP/E 26.56x
$83.67Latest market snapshot
Implied fair value · at ACAD's multiple
$38.4054.1% below market
3.15 SSNC EPS (TTM)×12.19x ACAD P/E=$38.40
Market $83.67Implied $38.40